Bohnacker, Thomas
Prota, Andrea E.
Beaufils, Florent
Burke, John E. http://orcid.org/0000-0001-7904-9859
Melone, Anna
Inglis, Alison J.
Rageot, Denise
Sele, Alexander M.
Cmiljanovic, Vladimir
Cmiljanovic, Natasa
Bargsten, Katja
Aher, Amol
Akhmanova, Anna http://orcid.org/0000-0002-9048-8614
Díaz, J. Fernando
Fabbro, Doriano
Zvelebil, Marketa
Williams, Roger L.
Steinmetz, Michel O.
Wymann, Matthias P.
Article History
Received: 5 August 2016
Accepted: 19 January 2017
First Online: 9 March 2017
Competing interests
: T.B., A.E.P., J.E.B., A.M., A.J.I., D.R., A.M.S., K.B., A.Ah., A.Ak., J.F.D., M.Z., R.L.W. and M.O.S. have no conflicting interests. F.B., V.C., N.C. and D.F. are currently employees of PIQUR Therapeutics, and V.C., N.C., D.F. and M.P.W. own shares of PIQUR Therapeutics. All novel compounds mentioned in this work are in the public domain, except for BKM120 (Novartis) and PQR309 (licensed to PIQUR by University of Basel).